Prime-2-CoV Beta

N/A

Report date: 2024/02/10 20:00:40

Base Information

Drug NamePrime-2-CoV Beta
Drug Alias NamePrime-2-CoV BetaPRIME-2-CoV_Beta
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEberhard-Karls Universitaet Tuebingen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSperansa Therapeutics GmbH
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A